This report shows public data only. Is this your organisation? If so, login here to view your full report.

HPE Growth Capital

PRI reporting framework 2017

You are in Direct – Private Equity » Overview


PE 01. Breakdown of investments by strategy (Private)

PE 02. Typical level of ownership (Private)

PE 03. Description of approach to RI (Private)

PE 04. Investment guidelines and RI

04.1. 組織のプライベートエクイティ投資のガイドラインは責任投資に言及しているかどうかを記載してください。

04.2. 組織の投資ガイドラインにおいて、ESG問題に対するスタッフやポートフォリオ企業のアプローチに対して期待されていることについて簡単に説明してください。 [任意]

In our fund agreements is incorporated explicitly that the portfolio companies shall not be engaged, directly or indirectly, in:
·production of and trade in weapons and ammunition; ·casinos and equivalent enterprises; ·production of and trade in tobacco and distilled alcoholic beverages and related products; ·human cloning for reproduction purposes; or ·research, development or technical applications relating to electronic data programs or solutions, which aim specifically at: (1)supporting any activity included in the restricted sectors referred to above; (2)internet gambling and online casinos; or (3)pornography, or which
are intended to enable to illegally: (1) enter into electronic data networks; or (2) download electronic data.
When providing financing to the research, development or technical applications relating to (i) human cloning for research or therapeutic purposes; or (ii) genetically modified organisms ("GMOs"), the Fund shall guarantee specific compliance with European Union legislation on GMOs and provide ethical guidelines and/or foresee appropriate monitoring procedures regarding such Investments.
Our portfolio companies have to confirm this on a bi-annually basis.